Geographic Analysis of Cancer Patients' Residences at Delafontaine Hospital
For patients and families
In plain language
An automatic summary of structured registry data. It is an orientation aid, not a substitute for the official protocol or a physician assessment.
- What is being studied
- This is an observational study: the protocol does not assign a study treatment.
- Who it may be relevant to
- Registry conditions: Neoplasms, Oncology Service, Health Services Accessibility, Health Inequalities. Basic parameters: No limits · All.
- What needs checking
- Age, condition and sex are only basic indicators. Prior treatment, laboratory values and other mandatory requirements appear in the eligibility criteria below.
- Where it takes place
- France
- Next step
- Save the trial, show it to the treating physician, and confirm current recruitment with the study center. Costs, documents and travel →
Unsure about the terms? Read our patient guide →
Overview
This study looks at where cancer patients treated at Delafontaine Hospital live and how far they have to travel for care. By mapping patients' home addresses (anonymized), the research will show how distance, transportation, and social factors affect access to cancer treatments and support services. The goal is to better understand inequalities in access to care and to improve patient support in the future.
Primary outcome measures
- Median travel time (minutes) from the patient's place of residence (IRIS centroid) to Delafontaine Hospital by the patient's usual mode of transport for oncology appointments. [Time frame: Assessed up to 5 years after first inclusion]
Eligibility criteria
Inclusion criteria
\- Adult patients treated for cancer in the oncology department of Delafontaine Hospital since January 1, 2020.
Exclusion criteria
\- Patients whose cancer treatment in the oncology department was completed before 2020.
Criteria are shown verbatim from the registry (in English). Final eligibility is always assessed by the study center.
Study design
- Observational model
- Cohort
Study locations
France · 1 center
- Centre Hospitalier de Saint-Denis — Saint-Denis
Identifiers
NCT: NCT07206914 · 0116_ONCOLOGIE